Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBPα)

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 1, 2008, Pages 77-81

  Khanna Gupta, Arati ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Myeloid leukemia; Post translational modification; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; LEUCINE ZIPPER PROTEIN; SUMO PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GRANULOPOIESIS; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; KARYOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION; SUMOYLATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; MYELOPOIESIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANS-ACTIVATION (GENETICS);

MUS;

EID: 44449136860     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.02.011     Document Type: Review

References (37)

1. Lekstrom-Himes J., and Xanthopoulos K.G. Biological role of CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273 (1998) 28545
2. Ramji D., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365 (2002) 561
3. Ron D., and Habener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with the transcription factors C/EBP and LAP and functions as a dominant negative regulator of gene transcription. Genes Dev. 6 (1992) 439
4. Tenen D.G., Hromas R., Licht J.D., and Zhang D.-E. Transcription factors, normal myeloid development, and leukemia. Blood 90 (1997) 489
5. Tenen D. Abnormalities of C/EBP alpha transcription factor: a major target in acute myeloid leukemia. Leukemia 15 (2001) 688
6. Muller B., and Pabst T. C/EBPa and the pathophysiology of acute myeloid leukemia. Curr. Opin, Hematol. 13 (2006) 7
7. Schuster M., and Porse B. C/EBPa: a tumour suppressor in multiple tissues?. Biochim. Biophys. Acta 1766 (2006) 88
8. Fuchs O. Growth-inhibiting activity of transcription factor C/EBPa, its role in hematopoiesis and its tumour suppressor or oncogenic properties in leukaemias. Folia Biologica (Praha) 53 (2007) 97
9. Darlington G.J., Rossi S.E., and MacDougald O.A. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 273 (1998) 30057
10. Diehl A.M. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. J. Biol. Chem. 273 (1998) 30843
11. Zhang P., Iwama A., Datta M.W., Darlington G.J., Link D.C., and Tenen D.G. Granulocyte development in C/EBP-alpha-/- mice: the role of expression of the IL-6 and G-CSF receptors. 39th Annual Meeting of the American Society of Hematology, San Diego, California, USA (1997) December
12. Wang N.-D., Finegold M.J., Bradley A., Ou C.N., Abdelsayed S.V., Wilde M.D., Taylor L.R., Wilson D.R., and Darlington G.J. Impaired energy homeostasis in C/EBP-alpha knockout mice. Science 269 (1995) 1108
13. Porse B., Pedersen T., Xu X., Lindberg B., Wewer U., Friis-Hansen L., and Nerlov C. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis. Cell 107 (2001) 247.
14. Timchenko N., Harris T., Wilde M., et al. CAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell Biol. 17 (1997) 7353
15. Timchenko N., Wilde M., and Darlington G. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol. Cell Biol. 19 (1999) 2936
16. Timchenko N.A., Wilde M., Nakanishi M., Smith J.R., and Darlington G.J. CCAAT/enhancer binding protein alpha (C/EBPa) inhibits cell proliferation through the p21(WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10 (1996) 804
17. Wang H., Iakova P., and Wilde M. C/EBP[alpha] arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol. Cell 8 (2001) 817-828
18. Radomska H., Basseres D., Zheng R., Zhang P., Dayaram T., Yamamoto Y., Sternberg D., Lokker N., Giese N., Bohlander S., Schnittger S., Delmotte M.-H., Davis R., Small D., Hiddemann W., Gilliland D., and Tenen D. Block of C/EBPa function by phosphorylation in acute myeloid leukemia with FLT-3 activating mutations. J. Expt. Med. 203 (2006)
19. Chapiro E., Russell L., Radford-Weiss L., Bastard C., Lessard M., Struski S., Cave H., Fert-Ferrer S., Barin C., Maarek O., Della-Valle V., Strefford J., Berger R., Harrison C., Bernard O., and Ngugen-Khac F. Overexpression of C/EBPA resulting from the translocation t(14;19) (q32;q31) of human precursor B-cell acute lymphoblastic leukemia. Blood 108 (2006) 3560.
20. Ross S., Radomska H., Wu B., Zhang P., Winnay, Bajnok N., Wright W., Schaufele F., and DGT MacDougald O. Phosphorylation of C/EBPalpha inhibits granulopoiesis. Mol. Cell Biol. 24 (2004) 675
21. Behre G., Singh S., Liu H., Bortolin L., Christopeit M., Radomska H., Rangatia J., Hiddemann W., Friedman A., and Tenen D. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248. J. Biol. Chem. 277 (2002) 26293
22. Wang G., and Timchenko T. Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein. Mol. Cell Biol. 25 (2005) 1325
23. Wang G., Iakova P., Wilde M., Awad S., and Timchenko T. Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev. 18 (2004) 912
24. Liu H.K., Perrier S., Lipina C., Finlay D., McLauchlan H., Hastie C.J., and Hundal H.S. Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of threonines 222/226. BMC Mol. Biol. 6 (2006) 7
25. Mukhopadhyay D., and Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci. 32 (2007) 286
26. Saitoh H., Pu R., Cavenagh M., and Dasso M. RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3736
27. Kim Y., Choi C., and Kim Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci U. S. A. 96 (1999) 12350
28. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., Pandolfi P., and Dejean A. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9 (2005) 769
29. Yamamoto H., Ihara M., Matsuura Y., and Kikuchi A. Sumoylation is involved in B-catenin-dependent activation of Tcf-4. EMBO J. 22 (2003) 2047
30. Gomez-del Arco P., Koipally J., and Georgopoulos K. Ikaros SUMOylation: switching out of repression. Mol. Cell Biol. 25 (2005) 2688
31. Yang S., and Sharrocks A. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13 (2004) 611
32. Gridwood D., Bumpass D., Vaughan O., Thain A., Anderson L., Snowden A., Garcia-Wilson E., Perkins N., and Hay R. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11 (2003) 1043
33. Song J., Durrin L., Wilkinson T., Krontiris T., and Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci U. S. A. 101 (2004) 14373
34. Subramanian L., Benson M., and Iniguez-Lluhi J. A synergy control motif within the attenuator domain of CCAAT/enhancer binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or Sumo-3. J. Biol. Chem 278 (2003) 9134
35. Kim J., Cantwell C., Johnson P., Pfarr C., and Williams S. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem 277 (2002) 38037-38044
36. Sato Y., Miyake K., Kaneoka H., and Iijima S. Sumoylation of CCAAT/enhancer binding protein a and its functional roles in hepatocyte differentiation. J. Biol. Chem 281 (2006) 21629
37. Geletu M., Balkhi M., Peer Zada A., Christopeit M.J., Pulikkan J., Trivedi A., Tenen D., and Behre G. Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. Blood 110 (2007) 3301